FARMALINE
InactiveNo longer registered with the KBO since 03-08-2026; last annual accounts for fiscal year 2025.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 95% of 10242 peers (2025). A comfortable equity buffer.
NBB · sector comparisonPosition among 10242 sector peers
Solvency
better than 95%
← weakest
strongest →
lowers risk · Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year €9k
lowers risk · Growing equity
Equity grew over 2023-2025. Profits are largely retained rather than distributed.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €36k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
28 d early
2024
20 d early
2023
19 d early
2022
24 d early
2021
34 d early
2020
31 d early
2019
18 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€36k▲ 34.1%
2024 · €27k
2018: €-42k
2019: €-21k
2020: €2k
2021: €14k
2022: €18k
2023: €19k
2024: €27k
2018 → 2025
Total assets
€40k▲ 27.8%
2024 · €31k
2018: €274k
2019: €178k
2020: €152k
2021: €125k
2022: €88k
2023: €56k
2024: €31k
2018 → 2025
Net result
€9k▲ 23.8%
2024 · €7k
2018: €4k
2019: €21k
2020: €23k
2021: €12k
2022: €4k
2023: €2k
2024: €7k
2018 → 2025
Working capital
€-1k
2024 · €4k
2018: €58k
2019: €-7k
2020: €6k
2021: €-8k
2022: €-438
2023: €11k
2024: €4k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€14k-€18k▲ 26.6%€19k▲ 9.0%€27k▲ 38.0%€36k▲ 34.1%
Operating result€14k-€5k▼ 61.9%€3k▼ 51.7%€10k▲ 271%€12k▲ 21.8%
Net result€12k-€4k▼ 69.1%€2k▼ 57.0%€7k▲ 358%€9k▲ 23.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 22% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €40k
Fixed assets
€37k▲ 62.3%
Current assets
€3k▼ 63.4%
Equity and liabilities €40k
Equity
€36k▲ 34.1%
Debt
€4k▼ 8.6%
The debt ratio falls from 14.7% to 10.5%: equity grows while debt is paid down.
Key figures and ratios
Solvency
89.5%▲
2024 · 85.3%
Current ratio
0.75▼
2024 · 1.87
Quick ratio
0.75▼
2024 · 1.87
Debt / equity
0.12▼
2024 · 0.17
ROE
25.4%▼
2024 · 27.5%
ROA
22.7%▼
2024 · 23.5%
Debt
€4k▼
2024 · €5k
Debt ≤ 1 year
€4k▼
2024 · €5k
Income taxes
€3k▲
2024 · €2k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€31k€40k▲
Fixed assets21/28€23k€37k▲
Financial fixed assets28€23k€37k▲
Current assets29/58€9k€3k▼
Amounts receivable within one year40/41€5k€2k▼
Trade receivables40€5k€2k▼
Other amounts receivable41€128€298▲
Cash at bank and in hand54/58€4k€1k▼
Equity and liabilities
Total equity and liabilities10/49€31k€40k▲
Equity10/15€27k€36k▲
Contributions10/11€12k€12k=
Reserves13€14k€23k▲
Non-distributable reserves130/1€849-
Reserves not available under the articles1311€849-
Tax-exempt reserves132€145€145=
Distributable reserves133€13k€23k▲
Amounts payable17/49€5k€4k▼
Amounts payable within one year42/48€5k€4k▼
Trade debts44€2k€2k▲
Suppliers440/4€2k€2k▲
Taxes, remuneration and social security45€3k€2k▼
Taxes450/3€3k€2k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€30k-
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€200-
Other operating charges640/8€528€544▲
Gross operating margin9900€40k€12k▼
Operating profit (loss)9901€10k€12k▲
Financial income75/76B€128€298▲
Recurring financial income75€128€298▲
Financial charges65/66B€80€50▼
Recurring financial charges65€80€50▼
Profit (loss) for the period before taxes9903€10k€12k▲
Income taxes67/77€2k€3k▲
Profit (loss) for the period9904€7k€9k▲
Profit (loss) for the period to be appropriated9905€7k€9k▲
Appropriation of the result
Profit (loss) to be appropriated9906€7k€9k▲
Transfer to equity691/2€7k€9k▲
To other reserves6921€7k€9k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
11-08
State Gazette act
Restructuring · End & cessationGeneral meeting · Merger · Dissolution4 facts ▸
State Gazette act
Restructuring · End & cessation
General meeting · Merger · Dissolution4 facts ▸
- General meeting, 06/05/2026
- Merger, absorption, 01/01/2026
- Dissolution, 2026-05-06
- Power of attorney, Randolph Corbeij
03-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
27-03
State Gazette act
RestructuringMerger · Accounting effect · Permanent representative5 facts ▸
State Gazette act
Restructuring
Merger · Accounting effect · Permanent representative5 facts ▸
- Merger, 3 maart 2026
- Merger, 3 maart 2026
- Merger, 3 maart 2026
- Accounting effect, 1 januari 2026
- Permanent representative, Eveline De Laender
2025
11-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
12-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Weakest financial yearnet €2k ▼57%
Net result drops to €2k, the lowest in the series.
31-12
Financial
Liquidity triplescurrent ratio 2.65
Current ratio from 0.98 to 2.65; short-term debt falls from €18k to €7k.
07-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
27-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Highest result since 2018net €23k ▲7.8%
Operating result €25k, net result €23k, both a record.
31-12
Financial
Liquidity times 24current ratio 2.20
Current ratio from 0.09 to 2.20; short-term debt falls from €8k to €5k.
13-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
03-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
03-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2016
06-12
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2024
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
09-02-2024
Resigned as Permanent representative
23-01-2024
Resigned as Director
Location & real-estate footprint
Registered office, Gent
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Nieuwevaart 1519000 GentGround area
5,935 m²
Building footprint
663 m²
Volume, LiDAR
2,255 m³
Parcel 44807G0029/00Z002, Flanders · tallest building 4.5 m, ±1 floor. Linked by address, not a title deed.
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44807G0029/00Z002 | Flanders | 5,935 m² | 1 · 663 m² | 4.5 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Connections & network
2 connected companiesNetwork connections
Shared address
→
Shared address
→
Acquisitions and mergers
2 transactionsTaken over by:COOP-APOTHEKEN
Taken over by:COOP-APOTHEKEN
Similar companies · same sector, comparable size
Apotheek Paricha
BE 0542.861.686
Zelzate · Eq €36k
PHARMACIE DIDIER ERGOT
BE 0442.951.092
Jodoigne · Eq €36k
Elisabeth in ’t Veld
BE 0747.595.628
Holsbeek · Eq €35k
ESPACE MEDICAL JUMET
BE 0524.908.471
Charleroi · Eq €35k
Custers Elke
BE 0723.585.257
Maaseik · Eq €36k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 2,266 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-12-2010
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
69109Other legal services
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.